Skip to content

DIGEST II

Evaluation of a DIGital tool to Support patients with irritable bowel syndrome ESTablish a healthier diet (DIGEST II) - A pilot study to assess the effectiveness and usability of a new smartphone-based application - DIGEST II

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57538
Enrollment
60
Registered
2025-02-10
Start date
2025-04-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Interventions

One group receives an intervention with a mobile application, which focus on personal dietary support and an informational brochure with general stress management support. The second group receives an

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: To be eligible to participate in this study, a potential subject must meet all of the following criteria:IBS diagnosis using Rome IV-criteria; Between 18 and 65 years old;Must have already identified which foods trigger their symptoms after completing an elimination diet;In possession of a smartphone that can access the internet (Wi-Fi or internet plan);In possession of an e-mail address.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study:Other gastrointestinal disorders and/or proven food allergies;No literacy in Dutch (not able to speak and read Dutch);Visually impaired;Being pregnant or in the lactation period;Participation in another human trial;Currently employed at the Division of Human Nutrition and Health;Legally incompetent;Not willing to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
The main study parameters are diet quality and perceived stress levels. 

Secondary

MeasureTime frame
The secondary objectives investigate the effect on IBS-related symptoms and the usability of the app-based interventions. 

Countries

Netherlands

Contacts

Public ContactM. Alst

Wageningen Universiteit

michelle.vanalst@wur.nl+31642817084

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)